What is cervical hyperirritability

Cervical cancer

Cervical cancer (cervical cancer) is a malignant disease of the lower part of the uterus. The disease is triggered by an infection with the human papillomavirus (HPV), which in most cases is transmitted through unprotected sexual intercourse. There is now a vaccination against two types of HPV, which can prevent up to 70 percent of all cervical cancers.

 

What is cervical cancer?

Cervical cancer is a malignant change in the cells of the cervix (cervix uteri). Medically, cervical cancer is called cervical cancer. Three quarters of the tumors are changes in the surface cells (squamous cell carcinoma); only a smaller part, about 20 percent of the cervical cancers, arise from glandular tissue in the upper part of the cervix (adenocarcinomas).

The cervix is ​​the lower, narrower third of the uterus. It protrudes into the upper part of the vagina and closes the body of the uterus together with the cervix at the bottom. It consists of connective tissue and muscles. The mucous membrane of the cervix is ​​flatter than that of the uterine cavity and consists largely of so-called squamous epithelial cells, which are mechanically very resilient and can renew themselves quickly and regularly. In addition, there are gland cells that produce tough mucus that protects the uterine cavity from germs from the vagina and closes it from the outside. During the fertile days and menstruation, the mucus thins and the cervix opens by a few millimeters. During pregnancy, on the other hand, the cervix closes the fruit cavity completely.

 

Cervical cancer is the third most common tumor disease in women

On one Around 6,500 new women develop cervical cancer in Germany every year, which means that there are 13.3 cases per 100,000 inhabitants each year. The mean age of onset for cervical cancer is 50.4 years, which is about 19 years below the mean age of onset for all cancers. The age distribution shows a first peak between 35 and 54 years and a second from 65 years. Since the introduction of the annual smear from the cervix (Pap test) as part of early cancer detection the incidence of the disease continued to decrease in Germany. Mortality from cervical cancer is also falling.